Development of a pilot-plant process for a nevirapine analogue HIV NNRT inhibitor

Organic Process Research and Development

Volumn 12, Issue 4, 2008, Pages 603-613

  Busacca, Carl A ^a   Cerreta, Mike ^a   Dong, Yong ^a   Eriksson, Magnus C ^a   Farina, Vittorio ^a   Feng, XuWu ^a   Kim, Ji Young ^a   Lorenz, Jon C ^a   Sarvestani, Max ^a   Simpson, Robert ^a   Varsolona, Rieh ^a   Vitous, Jana ^a   Campbell, Scot J ^a   Davis, Mark S ^a   Jones, Paul James ^a   Norwood, Daniel ^a   Qiu, Fenghe ^a   Beaulieu, Pierre L ^b   Duceppe, Jean Simon ^b   Haché, Bruno ^b   Brong, Jim ^a   Chiu, Fang Ting ^a   Curtis, Tom ^a   Kelley, Jason ^a   Lo, Young S ^a   Powner, Tory H ^a   more..

^a BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

^b BOEHRINGER INGELHEIM CANADA LTD   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 58149162950     PISSN: 10836160     EISSN: 1520586X     Source Type: Journal    
DOI: 10.1021/op8000756     Document Type: Article

References (48)

1. (a) Simoneau, B. U.S. Patent 6,420,359, 2002.
2. (b) Klunder, J. M.; Hoermann, M.; Cywin, C. L.; David, E.; Brickwood, J. R.; Schwartz, R.; Barringer, K. J.; Pauletti, D.; Shih, C.-K.; Erickson, D. A.; Sorge, C. L.; Joseph, D. P.; Hattox, S. E.; Adams, J.; Grob, P. M. J. Med. Chem. 1998, 41, 2960.
3. (c) Grozinger, K. G.; Byrne, D. P.; Nummy, L. J.; Ridges, M. D.; Salvagno, A. J. Heterocycl. Chem. 2000, 37, 229.
4. (d) Beaulieu, P. L.; Duceppe, J.-S.; Haché, B. Synthesis 2002, 4, 528.
5. (a) Knochel, P.; Bonnet, V.; Mongin, F.; Trécourt, F.; Breton, G.; Marsais, F.; Quéguiner, G. Synlett 2002, 6, 1008.
6. (b) Trécourt, F.; Breton, G.; Bonnet, V.; Mongin, F.; Marsais, F.; Quéguiner, G. Tetrahedron 2000, 56 (10), 1349. For a very similar finding see:
7. (c) Pierrat, P.; Gros, P.; Fort, Y. Synlett 2004, 13, 2319.
8. (a) Fleming, L; Henning, R.; Parker, D. C.; Plaut, H. E.; Sanderson, P. E. J. I Chem. Soc., Perkin Trans. 1 1995, 317.
9. (b) Jones, G. R.; Landais, Y. Tetrahedron 1996, 52, 7599.
10. (c) Hosomi, A.; Iijima, S.; Sukarai, H. Chem. Lett. 1981, 243.
11. (d) Tamao, K. Advances in Silicon Chemistry; JAI Press: Greenwich, CT, 1996; Vol. 3, pp 1-62.
12. (a) Knölker, H.-J.; Wanzl, G. Synlett 1995, 378.
13. (b) Fleming, I.; Henning, R.; Plaut, H. J. Chem Soc., Chem. Commun. 1984, 29 See also ref 5a.
14. (a) Kabalka, G. W.; Maddox, J. T.; Shoup, T. Org. Synth. 1996, 73, 116.
15. (b) Kabalka, G. W.; Shoup, T. M.; Goudagon, N. M. J. Org. Chem. 1989, 54, 5930.
16. (c) McKillop, A.; Sanderson, W. R. Tetrahedron 1995, 57, 6145.
17. (a) Buchwald, S. L.; Moradi, W. A. J. Am. Chem. Soc 2001, 123, 7996.
18. (b) Buchwald, S. L.; Fox, J. M.; Huang, X.; Chieffi, A. J. Am. Chem, Soc. 2000, 122, 1360.
19. (c) Buchwald, S. L.; Old, D. W.; Wolfe, J. P.; Palucki, M.; Kamikawa, K. U.S. Patent 6,307,087, CAN 135: 318588, 2001.
20. (d) Hartwig, J. F.; Hamann, B. C. U.S. Patent 6,057,456, CAN 132:293568, 2000.
21. (e) Hartwig, J. F.; Kawatsura, M. U.S. Patent 6,072,073, CAN 133:30376, 2000.
22. (f) Busacca, C. A.; Eriksson, M. C.; Kim, J.-Y. U.S. Patent 6,759,533, CAN 140:59670, 2004.
23. (g) Beare, N. A.; Hartwig, J. F. J. Org. Chem. 2002, 67, 541.
24. Krapcho, A. P. Synthesis 1982, 805.
25. (a) Uno, M.; Seto, K.; Ueda, W.; Masuda, M.; Takahashi, S. Synthesis 1985, 506.
26. (b) Yamanaka, H.; Sakamoto, T.; Katoh, E.; Kondo, Y. Chem. Pharm. Bull. 1988, 36, 1664.
27. (c) Yamanaka, H.; Sakamoto, T.; Katoh, E.; Kondo, Y. Heterocycles 1988, 27, 1353.
28. (d) Yamanaka, H.; Sakamoto, T.; Katoh, E.; Kondo, Y. Chem. Pharm. Bull. 1990, 38, 1513.
29. (e) Yamanaka, H.; Sakamoto, T.; Kondo, Y.; Suginome, T.; Ohba, S. Synthesis 1.99.1, 552.
30. (f) Sakamoto, T.; Kondo, Y.; Masumoto, K. Heterocycles 1993, 36, 2509 For a review see:
31. (g) Prim, D.; Campagne, J.-M.; Joseph, D.; Andrioletti, B. Tetrahedron 2002, 58, 2041.
32. Beletskaya, I. P.; Kashin, A. N.; Mitin, A. V.; Wife, R. Tetrahedron Lett. 2002, 43, 2539.
33. 2 led to acid 17 in high yield.
34. For recent examples, see: (a) Mannekens, E.; Tourwe, D.; Lubell, W. D. Synthesis 2000, 9, 1214.
35. (b) Springer, D. M.; Luh, B.-Y.; Branson, J. J.; McElhone, K. E.; Mansuri, M. M.; Gregor, K. R.; Nettleton, D. O.; Stanley, P. L.; Tramposch, K. M. Bioorg. Med. Chem. 2000, 8, 1087.
36. (a) Holmes, D. L.; Lightner, D. A. Tetrahedron 1996, 52, 5319.
37. (b) Silverman, R. B.; Lu, X.; Blomquist, G. D.; Ding, C. Z.; Yang, S. Bioorg. Med Chem. 1997, 5, 297.
38. (c) In situ React-IR might be suitable for monitoring this hydrolysis as well.
39. (a) Abiko, A.; Masamune, S. Tetrahedron Lett. 1992, 33, 5517.
40. (b) Periasamy, M.; Prasad, A. S. B.; Kanth, J. V. B. Tetrahedron 1992, 48, 4623.
41. (c) Meyers, A. L; Dickman, D. A.; Smith, G. A.; Gawley, R. E. Organic Syntheses; Wiley & Sons: New York, 1990; Collect. Vol. VII, p 530.
42. Black, T. H. Org. Prep. Proced. Int. 1989, 27, 179.
43. For a possible explanation, see: (a) Houk, K. N.; Washington, I. Org. Lett. 2002, 4, 2661.
44. (a) Hata, N. Bull. Chem. Soc. Jpn. 1986, 59, 2723.
45. (b) Hata, N.; Norisuke, Y.; Yagi, A. Chem. Lett. 1983, 309.
46. (c) Kaneko, C.; Okuda, W.; Karasawa, Y.; Somei, M. Chem. Lett. 1980, 547.
47. See Experimental Section.
48. Busacca, C. A.; Cerreta, M.; Varsolona, R.; Smoliga, J.; Lorenz, J. Vitous, J. U.S. Patent 7,309,700, CAN 1.43:35331.0, 2007.